Fundz

Amend Surgical Receives Funding For Suture-Less Nerve Repair Device

PRIVATEApr 11, 2023

Round Type

Funding Round

AlachuaManufacturingBiotechnologyHealth CareMedical Device

Investors

Wyss Institute At Harvard UniversityMichigan Pittsburgh Wyss Regenerative Medicine  Resource Center

Description

Amend Surgical, Inc., an Alachua-based medical device company, announced today that it has been awarded a substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center to commercialize a novel, suture-less solution for the repair of peripheral nerves. Tissure is a resorbable hydrogel membrane with a chitosan-based adhesive that has the adhesion and mechanical strength to potentially replace suture for the repair of peripheral nerve injuries. Tissure is easy to apply and will greatly simplify this challenging surgical procedure. Amend Surgical exclusively licensed the rights for this technology from the Wyss Institute at Harvard University in 2020.

Quick answer

Amend Surgical raised an undisclosed amount in a Funding Round round, dated April 11, 2023. Investors: Wyss Institute At Harvard University and Michigan Pittsburgh Wyss Regenerative Medicine  Resource Center. Amend Surgical is based in Alachua, Florida, United States.

How much did Amend Surgical raise?
Amend Surgical raised an undisclosed amount in a Funding Round round on April 11, 2023.
Who invested in Amend Surgical?
Wyss Institute At Harvard University and Michigan Pittsburgh Wyss Regenerative Medicine  Resource Center are named as investors in this round.
What does Amend Surgical do?
Amend Surgical leads the biopharmaceutical industry in promoting development of bone healing with NanoFuse, a bone graft substitute and bone void filler.
Where is Amend Surgical based and how big is it?
Amend Surgical is based in Alachua, Florida, United States.
Who are the decision-makers at Amend Surgical?
Fundz holds 1 contact at Amend Surgical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical Device and Manufacturing around the same time

Companies in the same sectors as Amend Surgical that raised within 45 days of this round, from Fundz verified event records.

  • InspireMD raised $42M on May 12, 2023.
  • MED-X raised $120K (Pre-Seed) on May 6, 2023.
  • Shape Memory Medical raised $4.8M (Seed) on April 24, 2023.
  • MedShift raised $108M (Funding Round) on April 20, 2023.
  • Harvard Apparatus Regenerative Technology raised $6M on March 31, 2023.
  • Flyte Aviation, Inc. raised $8M on March 23, 2023.

Who to call at Amend Surgical, and when

A new round usually means Amend Surgical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Amend Surgical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amend Surgical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Amend Surgical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Amend Surgical

Location

Alachua, Florida, United States

About

Amend Surgical leads the biopharmaceutical industry in promoting development of bone healing with NanoFuse, a bone graft substitute and bone void filler.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Amend Surgical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Amend Surgical's next move

See what Strategic adds

Amend Surgical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.